Sienna Financial Statements From 2010 to 2025
| SNNAQ Stock | USD 0.0001 0.00 0.00% |
Check Sienna Biopharmaceutica financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sienna Biopharmaceutica's main balance sheet or income statement drivers, such as , as well as many indicators such as . Sienna financial statements analysis is a perfect complement when working with Sienna Biopharmaceutica Valuation or Volatility modules.
Sienna |
Sienna Biopharmaceuticals Company Return On Equity Analysis
Sienna Biopharmaceutica's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Sienna Biopharmaceutica Return On Equity | -1.41 |
Most of Sienna Biopharmaceutica's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sienna Biopharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Sienna Biopharmaceuticals has a Return On Equity of -1.4097. This is 94.12% lower than that of the Healthcare sector and 96.13% lower than that of the Biotechnology industry. The return on equity for all United States stocks is notably higher than that of the company.
Sienna Biopharmaceuticals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sienna Biopharmaceutica's current stock value. Our valuation model uses many indicators to compare Sienna Biopharmaceutica value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sienna Biopharmaceutica competition to find correlations between indicators driving Sienna Biopharmaceutica's intrinsic value. More Info.Sienna Biopharmaceuticals is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sienna Biopharmaceutica's earnings, one of the primary drivers of an investment's value.About Sienna Biopharmaceutica Financial Statements
Sienna Biopharmaceutica shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Sienna Biopharmaceutica investors may analyze each financial statement separately, they are all interrelated. The changes in Sienna Biopharmaceutica's assets and liabilities, for example, are also reflected in the revenues and expenses on on Sienna Biopharmaceutica's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Sienna Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs in various therapeutic areas. It had filed for Chapter 11 bankruptcy on September 16, 2019. SIENNA BIOPHARMACEUTICA operates under Biotechnology classification in the United States and is traded on PNK Exchange. It employs 13 people.
Additional Tools for Sienna Pink Sheet Analysis
When running Sienna Biopharmaceutica's price analysis, check to measure Sienna Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sienna Biopharmaceutica is operating at the current time. Most of Sienna Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of Sienna Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sienna Biopharmaceutica's price. Additionally, you may evaluate how the addition of Sienna Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.